Forbion invests in innovative biotech companies across all stages of (bio-) pharmaceutical drug development.
Our portfolio is focused on novel therapeutics across different treatment modalities and disease areas, including small molecules, biologics and genetic medicines for oncology, CNS, autoimmune, cardiometabolic and rare diseases.
